Table 3.
Relationship between TPD52, KLF9, PKCϵ, and miR-223 expression and clinicopathological features of cervical cancer.
Clinical–pathological characteristics of cervical cancer patients | TPD52 expression | KLF9 expression | miR-223 expression | PKCϵ expression | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Features | Groups | N (%) | Expression status | Fold change | p-value | Expression status | Fold change | p-value | Expression status | Fold change | p-value | Expression status | Fold change | p-value |
Stage | I–II | 48 (48) | High | 27.0614 | 0.0001 | High | 0.68388 | 0.0001 | High | 1.2246 | 0.0001 | High | 0.05228 | 0.0001 |
III–IV | 52 (52) | Low | 1.62668 | 0.0001 | Low | 0.01752 | 0.0001 | Low | 2 | 0.0001 | Low | 0.10324 | 0.0001 | |
Metastasis | Metastatic | 40 (40) | High | 5.25275 | 0.0001 | High | 0.00733 | 0.0001 | High | 5 | 0.0001 | High | 0.08387 | 0.0001 |
Non-metastatic | 60 (60) | Low | 14.2051 | 0.0001 | Low | 0.13664 | 0.0001 | Low | 2.7869 | 0.0001 | Low | 0.07114 | 0.0001 |